Biovitrum Joins Diabetes Network
Stockholm - Biovitrum AB together with 12 distinguished research groups in Europe has established a network of excellence to gain insights into treatment opportunities of type-2 diabetes. The European Union has recently decided to issue a substantial grant to support the collaboration, to which the industrial partner Biovitrum contributes through the evaluation of genes and proteins that can be suitable targets for treatment of type-2 diabetes or other indications within the metabolic syndrome. In the longer term the collaboration may lead to the development of new drug candidates. The network includes renowned research groups from Sweden, Denmark, Finland, Germany, Italy, France and Spain. The Swedish groups are led by Prof. Ulf Smith, Gothenburg, while the overall co-ordinator for the project is Prof. Juleen Zierath, Stockholm.